Year |
Citation |
Score |
2010 |
Sinenko SA, Hung T, Moroz T, Tran QM, Sidhu S, Cheney MD, Speck NA, Banerjee U. Genetic manipulation of AML1-ETO-induced expansion of hematopoietic precursors in a Drosophila model. Blood. 116: 4612-20. PMID 20688956 DOI: 10.1182/Blood-2010-03-276998 |
0.373 |
|
2009 |
Roudaia L, Cheney MD, Manuylova E, Chen W, Morrow M, Park S, Lee CT, Kaur P, Williams O, Bushweller JH, Speck NA. CBFbeta is critical for AML1-ETO and TEL-AML1 activity. Blood. 113: 3070-9. PMID 19179469 DOI: 10.1182/Blood-2008-03-147207 |
0.461 |
|
2007 |
Liu Y, Chen W, Gaudet J, Cheney MD, Roudaia L, Cierpicki T, Klet RC, Hartman K, Laue TM, Speck NA, Bushweller JH. Structural basis for recognition of SMRT/N-CoR by the MYND domain and its contribution to AML1/ETO's activity. Cancer Cell. 11: 483-97. PMID 17560331 DOI: 10.1016/J.Ccr.2007.04.010 |
0.454 |
|
2006 |
Liu Y, Cheney MD, Gaudet JJ, Chruszcz M, Lukasik SM, Sugiyama D, Lary J, Cole J, Dauter Z, Minor W, Speck NA, Bushweller JH. The tetramer structure of the Nervy homology two domain, NHR2, is critical for AML1/ETO's activity. Cancer Cell. 9: 249-60. PMID 16616331 DOI: 10.1016/J.Ccr.2006.03.012 |
0.473 |
|
2005 |
Cheney MD, Liu Y, Gaudet JJ, Chruszcz M, Lukasik SM, Sugiyama D, Lary J, Cole J, Dauter Z, Minor W, Speck NA, Bushweller JH. Structural and Functional Characterization of the NHR2 and Runt Domains of AML1/ETO. Blood. 106: 2854-2854. DOI: 10.1182/Blood.V106.11.2854.2854 |
0.49 |
|
Show low-probability matches. |